Travere Therapeutics Inc (TVTX)
18.25
-0.01
(-0.05%)
USD |
NASDAQ |
Nov 22, 16:00
18.27
+0.02
(+0.11%)
After-Hours: 20:00
Travere Therapeutics Gross Profit Margin (Quarterly): 97.41% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 97.41% |
| June 30, 2024 | 96.19% |
| March 31, 2024 | 96.36% |
| December 31, 2023 | 89.87% |
| September 30, 2023 | 96.53% |
| June 30, 2023 | 95.49% |
| March 31, 2023 | 86.58% |
| December 31, 2022 | 97.04% |
| September 30, 2022 | 96.03% |
| June 30, 2022 | 96.21% |
| March 31, 2022 | 95.59% |
| December 31, 2021 | 97.21% |
| September 30, 2021 | 97.67% |
| June 30, 2021 | 96.98% |
| March 31, 2021 | 96.53% |
| December 31, 2020 | 95.94% |
| September 30, 2020 | 97.68% |
| June 30, 2020 | 96.92% |
| March 31, 2020 | 97.13% |
| December 31, 2019 | 96.31% |
| September 30, 2019 | 96.59% |
| June 30, 2019 | 97.81% |
| Date | Value |
|---|---|
| March 31, 2019 | 97.43% |
| December 31, 2018 | 96.34% |
| September 30, 2018 | 97.22% |
| June 30, 2018 | 97.15% |
| March 31, 2018 | 95.80% |
| December 31, 2017 | 97.22% |
| September 30, 2017 | 97.71% |
| June 30, 2017 | 97.95% |
| March 31, 2017 | 97.89% |
| December 31, 2016 | 96.78% |
| September 30, 2016 | 95.37% |
| June 30, 2016 | 96.93% |
| March 31, 2016 | 97.39% |
| December 31, 2015 | 97.50% |
| September 30, 2015 | 98.17% |
| June 30, 2015 | 97.35% |
| March 31, 2015 | 98.42% |
| December 31, 2014 | 97.60% |
| September 30, 2014 | 97.63% |
| June 30, 2014 | 99.39% |
| March 31, 2014 | 96.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
86.58%
Minimum
Mar 2023
97.68%
Maximum
Sep 2020
95.78%
Average
96.44%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 78.34% |
| Xtant Medical Holdings Inc | 58.37% |
| Myomo Inc | 75.43% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -325.8% |
| Return on Assets | -52.60% |
| Return on Invested Capital | -72.38% |
| Profit Margin (Quarterly) | -87.14% |
| Operating Margin (Quarterly) | -89.07% |
| Return on Net Operating Assets | -220.0% |